Elmar Nurmemmedov

Cofounder @ CellarisBio | Drug Discovery Platform Development

Role
Cofounder at Cellarisbio
Location
San Diego, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Elmar Nurmemmedov

I operate at the intersection of biotech innovation, platform strategy, and…

Experience

  1. Cofounder

    Cellarisbio

    Apr 2023 — Present · San Diego, CA, US

    Did you know that 85% of human proteome is still considered undruggable? There are undiscovered therapies hiding behind challenging / undruggable targets. At CellarisBio, we are developing drug discovery platform focused on cellular target engagement. The platform enables discovery for challenging / undruggable targets, such as transcription factors. Our mission is to expand the druggable proteome, de-risk and accelerate discovery of novel therapies.

Education

  • Lund University

    Doctor of Philosophy (PhD)

    2003 — 2007

  • Middle East Technical University

    Bachelor's degree

    1997 — 2001

  • Blekinge Institute of Technology

    Master of Business Administration (M.B.A.)

    2014 — 2016

  • Lund University

    Master's degree

    2001 — 2003

  • Middle East Technical University

    Minor Degree

    1997 — 2001

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Elmar Nurmemmedov — Cofounder at Cellarisbio in San Diego, US | Unifers